In agreement with a pattern recently reported in primary breast cancer (Lundgren et al., 2023), several genes from the highly intercorrelating gene cluster associated to hormone responsiveness (AR, PGR, ER signaling, ESR1, and FOXA1) emerged as interesting prognostic markers for MBC, both when expressed in PT and in DM. This evidence concerns the gene ESR1 and breast cancer.